1-8 of 8
Tao Lei
Close
Sort by
Journal Articles

A Prospective, Exploratory, Phase II Study of the Xpo-1 Inhibitor Selinexor in Combination with RCHOP in Double/Triple-Hit Large B-Cell Lymphoma

Cong Li, Tao Lei, Haifeng Yu, Xi Chen, Shuailing Peng, Shuiyun Han, Haiyan Yang
Journal: Blood
Blood (2023) 142 (Supplement 1): 6242.
https://doi.org/10.1182/blood-2023-184634
Published: 2023
Journal Articles

Real-World Analysis of Obinutuzumab-Based Immunochemotherapy in Follicular Lymphoma in Chinese Population

Xi Chen, Jieyu Xu, Haifeng Yu, Tao Lei, Cong Li, Haiyan Yang
Journal: Blood
Blood (2023) 142 (Supplement 1): 6311.
https://doi.org/10.1182/blood-2023-189282
Published: 2023
Journal Articles

Updated Results of a Prospective Study: Rituximab and Lenalidomide Plus Chidamide (RLC) for Patients with Relapsed/Refractory Angioimmunoblastic T-Cell Lymphoma

Cong Li, Huixian HU, Tao Lei, Haifeng Yu, Xi Chen, Shuailing Peng, Shuiyun Han, Haiyan Yang
Journal: Blood
Blood (2023) 142 (Supplement 1): 6221.
https://doi.org/10.1182/blood-2023-184830
Published: 2023
Journal Articles

PD-1 Blockade Combined with R-CHOP in Patients with Newly Diagnosed EBV-Positive Diffuse Large B-Cell Lymphoma: A Retrospective Analysis

Xi Chen, Yingying Chen, Tao Lei, Haifeng Yu, Cong Li, Yongwei Hong, Haiyan Yang
Journal: Blood
Blood (2023) 142 (Supplement 1): 4506.
https://doi.org/10.1182/blood-2023-182685
Published: 2023
Journal Articles

Phase II, Single-Center, Prospective Study of Intrathecal Thiotepa for the Prophylaxis of Secondary Central Nervous System Involvement in Highly Aggressive B-Cell Lymphoma

Cong Li, Tao Lei, Haifeng Yu, Xi Chen, Shuailing Peng, Shuiyun Han, Haiyan Yang
Journal: Blood
Blood (2023) 142 (Supplement 1): 6227.
https://doi.org/10.1182/blood-2023-184694
Published: 2023
Journal Articles

"Gentle Initiation” Rituximab, Lenalidomide and Zanubrutinib Chemo-Free Regimen Followed By Immunochemotherapy for Elderly/Frail Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma: An Investigator Initiated, Single Arm, Phase 2 Trial

Xi Chen, Tao Lei, Haifeng Yu, Cong Li, Shuiyun Han, Shuailing Peng, Haiyan Yang
Journal: Blood
Blood (2022) 140 (Supplement 1): 9452–9453.
https://doi.org/10.1182/blood-2022-164486
Published: 2022
Journal Articles

Rituximab and Lenalidomide Plus Chidamide Can be an Effective Chemotherapy Regimen for Patients with Relapsed/Refractory Angioimmunoblastic T-Cell Lymphoma

Cong Li, Tao Lei, Haifeng Yu, Xi Chen, Shuiyun Han, Shuailing Peng, Haiyan Yang
Journal: Blood
Blood (2022) 140 (Supplement 1): 3689–3690.
https://doi.org/10.1182/blood-2022-166370
Published: 2022
Journal Articles

Potential Metabolites with Diagnostic Value in Plasma for Angioimmunoblastic T-Cell Lymphoma By LC-MS Based Untargeted Metabonomics Study

Haiyan Yang, Tao Lei, Cong Li, Haifeng Yu, Zhongjian Chen
Journal: Blood
Blood (2019) 134 (Supplement_1): 5234.
https://doi.org/10.1182/blood-2019-129897
Published: 2019